BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 28
• 29
• 30

• Policy

  Cipher Pharmaceuticals Submits NDA Amendment For CIP-ISOTRETINOIN

  November 28, 2011

   · 

  2 min read
• FDA

  Perrigo Company Receives Final FDA Approval for Store Brand Equivalent to Generic Version of Mucinex®

  November 28, 2011

   · 

  3 min read
• BioMidwest

  Imaging3, Inc. to Open Exhibit at Radiological Society of North America (RSNA) 2011

  November 28, 2011

   · 

  2 min read
• Genetown

  Acceleron Pharma to Present at Two Upcoming Investor Conferences

  November 28, 2011

   · 

  1 min read
• Biotech Bay

  Fluidigm Corporation to Participate in the 23rd Annual Piper Jaffray Healthcare Conference

  November 28, 2011

   · 

  1 min read
• Lightlake Therapeutics Inc. Launches New Corporate Website, to Host Investor Conference Call With Q & A Session

  November 28, 2011

   · 

  1 min read
• BioMidwest

  RSNA 2011: Ziehm Imaging Inc. Presents Innovative Mobile C-Arms for Virtually Unlimited Imaging

  November 28, 2011

   · 

  4 min read
• Bio NC

  Targacept, Inc. Announces Participation in Upcoming Conferences

  November 28, 2011

   · 

  1 min read
• Genetown

  Seventy-Four Percent of Surveyed U.S. Neurologists Indicate They Will Prescribe Biogen Idec, Inc. (Massachusetts)'s BG-12 for the Treatment of Relapsing-Remitting Multiple Sclerosis

  November 28, 2011

   · 

  1 min read
• Drug Development

  InViragen Initiates a Phase 2 Clinical Study of DENVax, a Recombinant, Tetravalent Dengue Vaccine

  November 28, 2011

   · 

  1 min read